Bone metabolism and adipokines: are there perspectives for bone diseases drug discovery?
Authors:
- Morena ScoteceMSMorena Scotece
- Javier CondeJavier Conde
- Vanessa AbellaVAVanessa Abella
- Verónica LópezVLVerónica López
- Jesús PinoJPJesús Pino
- Francisca LagoFLFrancisca Lago
- Juan J Gómez-ReinoJGJuan J Gómez-Reino
- Oreste GualilloOreste Gualillo
- 24 May 2014
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Discovery
- Vol. 9 (8) , 945-957
Abstract
Over the past 20 years, the idea that white adipose tissue (WAT) is simply an energy depot organ has been radically changed. Indeed, present understanding suggests WAT to be an endocrine organ capable of producing and secreting a wide variety of proteins termed adipokines. These adipokines appear to be relevant factors involved in a number of different functions, including metabolism, immune response, inflammation and bone metabolism. In this review, the authors focus on the effects of several adipose tissue-derived factors in bone pathophysiology. They also consider how the modification of the adipokine network could potentially lead to promising treatment options for bone diseases. There are currently substantial developments being made in the understanding of the interplay between bone metabolism and the metabolic system. These insights could potentially lead to the development of new treatment strategies and interventions with the aim of successful outcomes in many people affected by bone disorders. Specifically, future research should look into the intimate mechanisms regulating peripheral and central activity of adipokines as it has potential for novel drug discovery.Keywords
This publication has 101 references indexed in Scilit:
- Interactions between Serum Adipokines and Osteocalcin in Older Patients with Hip FractureInternational Journal of Endocrinology, 2012
- Challenges and Opportunities of Defining Clinical Leptin ResistanceCell Metabolism, 2012
- Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humansDiabetologia, 2011
- Human articular chondrocytes express ChemR23 and chemerin; ChemR23 promotes inflammatory signalling upon binding the ligand chemerin21-157Arthritis Research & Therapy, 2010
- Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivoProceedings of the National Academy of Sciences, 2008
- Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic interventionAnnals of the Rheumatic Diseases, 2007
- Mice lacking inhibitory leptin receptor signals are lean with normal endocrine functionJournal of Clinical Investigation, 2007
- Neutrophil Gelatinase-associated Lipocalin, a Siderophore-binding Eukaryotic ProteinBioMetals, 2006
- The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle‐aged menClinical Endocrinology, 2005
- Ultradian Oscillations of Leptin Secretion in HumansBiochemical and Biophysical Research Communications, 1996